Your RCM partner shouldn’t be something you outgrow

Shelley Badilla
Senior Vice President, Sales

Why the best revenue cycle partnerships evolve alongside your health system

The greatest test of an RCM partnership isn't how it performs today, but how well it performs after your organization has improved. A partner that helps stabilize today's revenue cycle should be able to support tomorrow's growth as well.  

Many outsourcing relationships begin with a fixed statement of work, defined staffing assumptions, and a narrowly scoped operating model. Those assumptions rarely survive a growing health system. A denials engagement built for a $400 million organization looks different at $800 million. A merger changes the payer mix. New service lines introduce new operational complexity. Patient volumes rise. The RCM vendor hasn't failed, necessarily. The organization has simply outgrown the original design of the engagement. What once felt like a strategic partnership now becomes an operational constraint, forcing leaders to renegotiate the relationship or begin another vendor search.


Growth shouldn't trigger another vendor search

Health systems don't scale in a straight line. A prior authorization workflow designed around one payer may be strained under a merger or other unforeseen circumstance. This is where many vendor relationships begin to fracture. Execution wasn't the issue. Adaptability is. The initial engagement couldn’t expand, adjust, or absorb new complexity without an entirely new procurement cycle. 


The market keeps answering the wrong question

Recent KLAS research suggests providers are increasingly evaluating partners on strategic alignment, flexibility, and long-term collaboration, rather than execution of KPIs alone. In other words, an organization that shows up as an extension of their team, not a software stack with a support line attached.  

Meanwhile, a large share of vendor messaging still centers on technological capabilities: faster automation, broader AI coverage, and greater workflow reach. Those are real advantages, but they answer a different question than the one CFOs are asking. Technology answers one question: Can the platform perform the work? The relationship answers another: Will this partner still fit the organization after the next acquisition, payer shift, or strategic change?


What it looks like to build for scale from day one

Access Healthcare's approach starts from a different premise: the engagement should expand with the client, not require the client to expand around the engagement. In practice, that means: 

  • Starting with the functional need. Denials, prior authorization, coding, or A/R follow-up can each stand on their own to address initial revenue leakages. Clients don't need to commit to a full suite of RCM services to prove value in one area first. 

  • Adding scope without a re-platform. When a client is ready to expand, the expansion occurs within the existing relationship rather than through a new RFP. 

  • Scaling with change. Merger activity, payer mix shifts, and EHR transitions shouldn't require rebuilding the engagement. 

  • Keeping the operating model people-first. Technology supports the work behind the scenes; it doesn't dictate the shape of the relationship. 

This is the difference between an expertise-led model and a technology-first one. Technology-first models begin with their platform and then wrap services around it. An expertise-led model begins with the operational challenge and applies people, processes, and technology in whatever combination best fits the client.


The best RCM partnership is the one you never have to replace

Every health system CFO wants the same thing: predictable performance without the operational risk of tearing out a working system to get there. That goal falls apart if the RCM partner has a shelf life built into the contract.  

The real measure of a strong revenue cycle partnership is how well it works after the organization has changed shape. It should be a partnership built to grow alongside a health system, past short-term stability into long-term revenue certainty. Here’s one of our case studies where we’ve evolved with our client: https://www.accesshealthcare.com/case-study/turning-revenue-loss-inot-revenue-gains 

If your current RCM engagement is beginning to feel constrained by where your organization is headed, it's worth asking, “Was our vendor relationship designed to evolve with us or simply designed to deliver?”

Let’s build something stronger together.

Contact us to explore how our holistic approach to revenue integrity—powered by automation, analytics, and human insight—can support your goals.

About the Author

Shelley Badilla is Senior Vice President at Access Healthcare, where she leads growth across the healthcare market. She directs the go-to-market teams responsible for improving providers' revenue cycle outcomes. With over 30 years in healthcare, she has spent her career helping organizations solve hard problems around reimbursement, cost, and the day-to-day realities of running a complex operation—and building the kind of partnerships that hold up over time.